Life sciences businesses face challenges in today’s climate, ranging from M&A activity to economic trends and regulatory burdens.
But despite these challenges, the industry continues to make exciting progress that is changing lives. As drug development advances, breakthroughs could help the sector achieve even greater success in 2022.
Cybersecurity
With a high-value trove of data, life sciences businesses need to prepare for cybersecurity challenges. It includes protecting sensitive information, ensuring regulatory compliance, and avoiding reputational damage and financial loss associated with data privacy violations or breaches of third-party contracts.
As digital technology advances and cloud services increase, companies that fail to incorporate cybersecurity into their digital strategy miss out on opportunities for efficiencies and innovation. Managed IT services for life sciences companies requires well-defined roles and responsibilities, rigid protocols for third-party integrations, ongoing monitoring, effective communication and adequately trained employees.
Life sciences enterprises are also more susceptible to cyber attacks than other industries because they have sensitive information and intellectual property. It makes them a prime target for hackers who can steal and monetize their data for their gain.
Globalization
The swift cross-border movement of people and things is known as globalization. It’s an economic concept that brings a cultural element as ideas and traditions travel worldwide.
Despite the benefits of globalization, there are some challenges that life sciences businesses need to prepare for. For example, it’s a challenge to communicate with a foreign audience or market your product or service in a way that resonates with that specific culture.
It’s also essential to understand how to protect intellectual property rights best. It is necessary if you’re working with a country that might not adhere to international laws and policies regarding life sciences.
Uncertainty
Life sciences businesses need to prepare for various challenges due to uncertainty. These include new products that may or may not meet market demand, increased regulation and national specifications, competitors’ pending new product launches, and price fluctuations after a natural disaster shut down a supplier.
Rather than wait to make decisions, life science companies must take an adaptive approach that enables them to respond rapidly to changing conditions. It involves embedding resilience at the employee level, developing talent and empowering employees to make quick decisions.
It requires a clear understanding of the current state of the industry and the potential future landscape. Using this analysis, life sciences leaders can determine the best strategy at each level of uncertainty.
Inflation
Inflation is the broad rise in goods and services prices over time. It can affect consumers and businesses in different ways.
Life sciences businesses can face increased challenges due to inflation, which has soared across all major economies in recent months. Pent-up demand, supply chain issues and government spending have pushed inflation to nearly 8 percent.
High inflation levels can erode the purchasing power of money and decrease households’ spending power, which could stunt economic growth. Inflation is caused by various factors, including cost-push (expenses in producing goods and services) and demand-pull (demand for products that outpaces the available supply).
Risk Management
As life sciences businesses adapt and grow, they face risk management challenges. Whether they are facing product safety, product liability, product recalls, or dealing with the effects of the coronavirus pandemic, there is always a need to assess risks and implement appropriate strategies for risk mitigation.
To prioritize risks, companies turn to a variety of risk assessment tools. These include cause and effect analysis, the ‘Five Whys,’ fault tree, and failure mode effect analysis.
The key to a successful risk management strategy is identifying and ranking your priority risks and taking action as quickly as possible. It requires good documentation practices, clear action plans and cross-functional input using the right tools.
